Trial Profile
A Comparison of Psychosocial Outcomes Following Tadalafil Once a Day or PDE5 Inhibitor As Needed in Men With Erectile Dysfunction
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Oct 2021
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary) ; Sildenafil
- Indications Erectile dysfunction
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Eli Lilly and Company
- 27 Dec 2012 New source identified and integrated (German Clinical Trials Register record: DRKS00004102).
- 18 Apr 2010 Results presented at the 25th Congress of the European Association of Urology.
- 06 Oct 2009 Additional location identified as reported by ClinicalTrials.gov.